- Home
- ENSC vs GITS Comparison
ENSC vs GITS Comparison
Compare ENSC & GITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- GITS
- Stock Information
- Founded
- ENSC 2003
- GITS 2018
- Country
- ENSC United States
- GITS South Korea
- Employees
- ENSC N/A
- GITS N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- GITS
- Sector
- ENSC Health Care
- GITS
- Exchange
- ENSC Nasdaq
- GITS Nasdaq
- Market Cap
- ENSC 3.4M
- GITS 3.4M
- IPO Year
- ENSC N/A
- GITS N/A
- Fundamental
- Price
- ENSC $2.38
- GITS $2.02
- Analyst Decision
- ENSC
- GITS
- Analyst Count
- ENSC 0
- GITS 0
- Target Price
- ENSC N/A
- GITS N/A
- AVG Volume (30 Days)
- ENSC 455.1K
- GITS 2.9M
- Earning Date
- ENSC 05-13-2025
- GITS 07-15-2025
- Dividend Yield
- ENSC N/A
- GITS N/A
- EPS Growth
- ENSC N/A
- GITS N/A
- EPS
- ENSC N/A
- GITS N/A
- Revenue
- ENSC $6,224,081.00
- GITS N/A
- Revenue This Year
- ENSC N/A
- GITS N/A
- Revenue Next Year
- ENSC $1,381.48
- GITS N/A
- P/E Ratio
- ENSC N/A
- GITS N/A
- Revenue Growth
- ENSC 256.35
- GITS N/A
- 52 Week Low
- ENSC $1.62
- GITS $0.87
- 52 Week High
- ENSC $14.67
- GITS $9.78
- Technical
- Relative Strength Index (RSI)
- ENSC 49.99
- GITS N/A
- Support Level
- ENSC $2.12
- GITS N/A
- Resistance Level
- ENSC $2.57
- GITS N/A
- Average True Range (ATR)
- ENSC 0.21
- GITS 0.00
- MACD
- ENSC 0.04
- GITS 0.00
- Stochastic Oscillator
- ENSC 53.87
- GITS 0.00
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About GITS Global Interactive Technologies Inc. Common Stock
Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.